According to Stratistics MRC, the “Global Adhesion Barrier Market” is accounted for $582.21 million in 2018 and is expected to reach $1,213.24 million by 2027 growing at a CAGR of 8.5% during the forecast period. Some of the key factors influencing the market growth include growth in the geriatric population and corresponding age-related chronic diseases, growing volume of surgical procedures and sports-related injuries, and increasing awareness about the medical implications of adhesions. However, reluctance towards the usage of adhesion barriers among surgeons is restraining market growth.
Request for sample here: “Global Adhesion Barrier Market”
An adhesion barrier is utilized for diminishing internal abnormal scarring and isolating the internal organs and tissues therefore avoiding organ adhesion. These products are mainly employed in many surgeries. Adhesion barriers are generally utilized in cardiovascular surgeries to heal the coronary artery. The gel and film formulations of adhesion barriers are widely utilized as compared to the liquid formulation.
Driver: Increase in the volume of surgeries and sports-related injuries.
Growing incidence of sports injuries is increasing the demand for these products. Sprains and strains are the common sort of sports injuries accounted worldwide. According to Stanford Children’s Health, a San Francisco-based healthcare system concentrating on pediatric and obstetric care, more injuries in the U.S. happen in 30 million children participating in any sport and one-third of all injuries that arise in childhood are sports related. Therefore, the increase in the number of surgical processes for the handling of sports injuries is prompting the demand for adhesion prevention products, thus, driving the growth of the market.
Opportunity: Increasing awareness about the medical implications of adhesions.
Post-surgical adhesions are typical problems in different kinds of surgeries. The information and understanding of adhesions and adhesion problems have expanded in the most recent decade. Different surgical associations and medical centers, are concentrating on rising the awareness about post-surgical adhesion formation and the accessible anti-adhesive products to control these complexities. The International Adhesions Society is involved in spreading information about adhesion-related disorders and their treatment and prevention to patients, specialists, and other healthcare experts. This is likely to expand the significance of anti-adhesion products in surgical procedures. Additionally, high awareness about adhesion disorders in Asia Pacific countries is likely to drive the demand for anti-adhesion products in the coming years.
By application, the gynecological surgeries segment is anticipated to hold considerable market share during the forecast period due to factors such as the rising number of C-section surgeries, high incidence of pelvic/uterine cancer, and increasing prevalence of conditions such as infertility and incontinence.
Request for customization here: “Global Adhesion Barrier Market”
By geography, Asia Pacific region is anticipated to hold considerable market share during the forecast period due to healthcare expenditure, growing volume of surgical techniques, and spreading awareness about adhesions and their complications.
Some of the key players in global Adhesion Barrier market are Anika Therapeutics, Inc., Sanofi Group, PlantTec Medical GmbH, C. R. Bard, Inc., Medtronic Plc, Johnson & Johnson, FzioMed, Inc., Becton Dickinson and Company, Baxter International, Inc., MAST Biosurgery AG, Integra LifeSciences Holdings Corporation, Getinge AB, Betatech Medical, Innocoll Holdings, and Ethicon US, LLC.
Baxter International, Inc.: In Dec 2019, Baxter International, Inc. acquired Seprafilm Adhesion Barrier and related assets from French drug maker Sanofi to expand its advanced surgery portfolio. This acquisition is part of Baxter's strategy to acquire products that are a strong fit with its leading hemostat and sealant portfolio for optimized patient care in the operating room.
For more information fill in the Inquiry form at: “Global Adhesion Barrier Market”
FzioMed,Inc.: In Oct 2018, FzioMed, Inc., launched a new anti-adhesion product Oxiplex/IU®adhesion barrier gel for intrauterine surgery. Oxiplex/IU® is CE marked and available in the European Union. It is an absorbable, synthetic viscoelastic gel that is applied following intrauterine surgery to preserve uterine integrity and improve surgical outcomes by reducing post-surgical adhesions.
About Stratistics MRC:
StratisticsMRC Pvt Ltd. is a market research firm serving the fortune 500 companies across the world with market intelligence. We offer a wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full-Time Equivalent (FTE) services in the research world. We explore market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.
We have a core research team with research analysts across the industry verticals to serve our varied customers such as technology suppliers, manufacturers, distributors, end-users, consulting companies, investment firms and research institutes. We ensure that our research reports, white papers, policy briefs provide result-oriented findings and recommendations. Our research reports help you to make better decisions in building the organization present in a global scenario. Our consultancy services offer you with the highly qualified professional research team to match your research needs. We are in the process of addressing the challenges of our clients and able to deliver the quality outputs to meet their business objectives and goals in a potential way. We invest more in building our teams and enhance our client relationships across the geographies where we work.
Contact:
James Lamb
United States Direct:+1-301-202-5929
Email: sales@strategymrc.com
Corporate Sales Specialist
